The DeSci track is making waves again, Pump.Science's new launch platform attracts follow.

The decentralized science (DeSci) track has recently seen new developments. The highly anticipated project Pump.Science has announced the launch of a new token launch platform next week, and as soon as the news broke, the prices of related tokens surged. The co-founder of Pump.Science previously stated plans to launch 20 new compound tokens by the end of 2024, and it seems that this plan is now being implemented ahead of schedule.

However, the DeSci sector has been performing poorly in recent months. Influenced by external factors, the market value of the Pump.Science official token has plummeted, and other DeSci projects have also experienced varying degrees of decline during the same period. This emerging field, once seen as capable of driving the large-scale application of cryptographic technology, now seems to be in trouble.

Can the new launch platform revitalize DeSci?

According to public information, the operation mechanism of the new platform Pump.Science is as follows:

• Users can pair a certain compound with tokens for listing on the platform.
• Users can support related compound research by buying and selling tokens.
• 79% of the tokens are issued through Bonding Curve
• When the token market value reaches 303 Sol, the Bonding Curve closes.
• 82 Sol liquidity will be transferred to Meteora for trading
• 3 Sol for payment of related experimental costs

It is worth noting that the new platform will adopt a dynamic fee structure to prevent issues such as bot front-running.

• Fees can be as high as 99.99% within the first 150 blocks (approximately 2 minutes)
• The fees between blocks 150-250 are rapidly decreasing.
• This design aims to reduce early speculative behavior.

The new compound project will airdrop a certain share to official token holders. Pump.Science's move is undoubtedly an attempt at self-rescue, aiming to inject new vitality into the weakened DeSci track. Whether DeSci can regain its former popularity in the current market environment remains to be seen.

The EGS project has sparked heated discussions

The compound project EGS, which will soon be launched by Pump.Science, has recently attracted significant attention. The project started a 24-hour pre-sale on February 7, raising a total of 1223 Sol. The project team subsequently announced that they would refund 91.87% of the raised funds, retaining only 100 Sol for launch and liquidity support. This "over-raised high refund" strategy has sparked heated discussions and is considered to have pioneered the DeSci project.

EGS stands for Epigallocatechin Gallate and Sulforaphane, two compounds with anti-aging potential. The former is the main active ingredient in green tea, while the latter is derived from cruciferous vegetables. Studies show that both substances have significant effects on extending the lifespan of model organisms.

The presale strategy of the EGS project is similar to that of previous popular projects, reducing risks through a high refund ratio. However, whether this topic marketing can translate into long-term value remains to be seen. As the founder of Pump.Science said, DeSci faces the challenge of balancing ideals and reality.

Overview of New Compound Projects

Pump.Science plans to launch multiple new compound projects, including:

• Punicalagin & Berberine: both have antioxidant and metabolic regulation effects.
• Resveratrol & Berberine: May synergistically enhance longevity and metabolic effects
• Ginsenoside Rh2: Ginseng extract with multiple biological activities
• Aspalathin & Caffeine: A combination that balances stimulant effects
• Gossypol & Catechin Hydrate: May jointly regulate cellular stress responses
• Biotin & Berberine: Synergistically improve metabolism and mitochondrial function
• Urolithin A & EGCG: Support mitochondrial function and longevity pathways
• Berberine & Quercetin: Improve glucose regulation and nutrient absorption
• Hesperidin & DHM: Enhance detoxification and metabolic recovery capabilities
• EGCG: Green tea extract with strong antioxidant properties
• Caffeine: Enhances cognition and physical performance, may reduce the risk of early death.
• Artemisinin: a compound derived from sweet wormwood, with multiple medical potentials.

Recently, as a research institution once again affirmed the DeSci track, the prices of related tokens have rebounded. However, whether DeSci can regain its past glory still requires time to verify. Investors should closely follow the progress of various projects and cautiously assess their long-term development potential.